Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Odanacatib biomarker substudy of Protocol 018 in postmenopausal women with osteoporosis
2008-005874-11Phase 3Completed
- Sponsor
- MSD France
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoporosis comparing Odanacatib + vitamin D + calcium with Placebo + vitamin D + calcium (2 arms). Primary endpoints: Baseline phenotypic distribution of physical function measures, Correlation of clinical endpoint measurements with mRNA expression levels and 2 more. Started Mar 2009; status: completed.
02
Drugs
odanacatib
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2008-005874-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005874-11.